Publication date: Feb 18, 2025

Kidney transplant recipients are at increased risk of severe outcomes from coronavirus disease 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination has been shown to reduce hospitalisation and mortality rates in kidney transplant recipients, but vaccine hesitancy remains a concern. We surveyed kidney transplant recipients in a single centre to examine their perceptions and attitudes towards SARS-CoV-2 vaccination. A cross-sectional survey of kidney transplant recipients was conducted between June 2021 and August 2021. Questionnaire responses collected included demographic data, intention to receive SARS-CoV-2 vaccine and factors related to vaccine acceptance or hesitance. Predictors and reasons for vaccine acceptance were analysed. In the sampled cohort of 313 respondents, the vaccine acceptance rate was 75%; 61% of the respondents were aged 51-70 years, and 31% had transplant vintages of 10-20 years. In a multivariable model, transplant physicians’ recommendation (odds ratio [OR] 4. 1, 95% confidence interval [CI] 2. 4-7. 1, P < 0. 001), male gender (OR 2. 3, 95% CI 1. 3-4. 0, P = 0. 003) and transplant vintage of

Semantics

Original Article